Agilent Technologies Combines CGH and SNP Assays on Same Microarray, Creating a Unique Cytogenetics Tool

Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.

Related Posts

Comments are closed.